<?xml version="1.0" encoding="UTF-8"?>
<p id="para0013">Since these trials only included adults, studies on LA-ART among adolescents have been limited to interest surveys. In a study of U.S. AYA in HIV care, nearly 90% of those surveyed indicated a willingness to try injectable ART, with greater interest at higher viral loads 
 <xref rid="bib0021" ref-type="bibr">[21]</xref>. Interest in taking a break from daily pills was measured in the BREATHER trial, in which some adolescents were randomized to a regimen that included weekends off from taking ART 
 <xref rid="bib0022" ref-type="bibr">[22]</xref>. Adolescents expressed a strong preference for the weekends off regimen, with 98% of participants agreeing to participate in a two-year follow-up study 
 <xref rid="bib0022" ref-type="bibr">[22]</xref>.
</p>
